Clinical Trials Directory

Trials / Completed

CompletedNCT00003186

Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer

Dynamic In Vivo Lymphography and Sentinel Node Biopsy in Colorectal Cancer: A Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
Roswell Park Cancer Institute · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Diagnostic procedures, such as lymphography, may improve the identification of patients with metastatic colorectal cancer. PURPOSE: Clinical trial to study the effectiveness of lymphography in determining the presence or absence of metastatic colorectal cancer in patients.

Detailed description

OBJECTIVES: I. Confirm that injection of isosulfan blue into the mucosa or serosa immediately adjacent to a colorectal cancer results in the lymphatic transport of that agent initially to a specific regional lymph node that can readily be identified on visual inspection, dissected, and histologically evaluated for the presence or absence of metastatic disease. OUTLINE: All patients receive an injection of isosulfan blue into peritumor serosa upon intraoperative identification of the primary tumor, prior to mesenteric mobilization. If colonoscopy is otherwise indicated, the injection may be delivered to the peritumor mucosa via colonoscopy during the case. The mesentery adjacent to the injection is inspected and the lymphatic pattern and nodes demonstrated by the isosulfan blue are diagrammed and photographed. The sentinel node(s) are surgically dissected and evaluated. If needed, a second injection of isosulfan blue may be given. Prior to mobilization of liver for resection of metastases, isosulfan blue is injected subcapsularly around the metastatic lesion. PROJECTED ACCRUAL: There will be 10 patients accrued into this study.

Conditions

Interventions

TypeNameDescription
DRUGisosulfan blue
PROCEDURElymphangiography
PROCEDUREsentinel lymph node biopsy

Timeline

Start date
1997-04-01
Primary completion
2005-03-01
First posted
2004-05-19
Last updated
2013-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00003186. Inclusion in this directory is not an endorsement.